Monopar Therapeutics MNPR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$298.8K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 13.22% to 16.44% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +137,220 | 3.4% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +58,012 | 1.3% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +43,683 | 0.6% |
| Morgan Stanley | Public Company | 2026/Q3 | +20,118 | 0.6% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +20,118 | 0.6% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +8,247 | 3.2% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +7,738 | 0.1% |
| Rafferty Asset Management, LLC | Mutual Fund | 2026/Q3 | +5,959 | 0.1% |
| Chandler Robinson | Individual/Insider | 2026/Q3 | +5,457 | 2.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +5,980 | 0.1% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +157,423 | 2.3% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +143,339 | 2.1% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +71,224 | 3.0% |
| Longaeva Partners L.P. | Mutual Fund | 2026/Q3 | +55,834 | 0.8% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +50,884 | 1.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 3 Nov 2026 | Kim Tsuchimoto | Director | Derivative Exercise and Sale | -4,090 | $72.21 | 11,486 |
| 1 Nov 2026 | Raymond Anderson | Independent Director | Derivative Exercise and Sale | -3,142 | $70.04 | 5,373 |
| 19 Oct 2026 | Chandler Robinson | Chief Executive Officer | Sale to Issuer | -597 | $92.59 | 166,942 |
| 30 Sep 2026 | Christopher Starr | Co-Founder & Independent Executive Chairman of the Board | Derivative Exercise and Sale | -8,400 | $79.67 | 15,053 |
| 29 Sep 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Sale | -1,944 | $79.67 | 58,054 |
| 29 Sep 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Retained | +2,440 | – | 58,054 |
| 29 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Sale | -4,344 | $79.67 | 167,539 |
| 29 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Retained | +5,457 | – | 167,539 |
| 29 Sep 2026 | Quan Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | Derivative Exercise and Sale | -180 | $79.67 | 2,655 |
| 29 Sep 2026 | Quan Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | Derivative Exercise and Retained | +434 | – | 2,655 |
| 23 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Sale | -29,056 | $89.79 | 162,082 |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Derivative Exercise and Sale | -1 | $111.26 | 5,065 |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Other Derivative Acquisition | +1,380 | $0.01 | – |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Derivative Exercise and Retained | +1,379 | $0.01 | 5,065 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Automatic Disposition | -4,090 | $113.84 | 11,486 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Derivative Exercise and Sale | -4,090 | $113.84 | 11,486 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Other Derivative Acquisition | +4,090 | $30.00 | 8,140 |
| 24 Aug 2026 | Raymond Anderson | Independent Director | Derivative Exercise and Sale | -3,142 | $113.05 | 5,373 |
| 24 Aug 2026 | Raymond Anderson | Independent Director | Other Derivative Acquisition | +3,142 | $30.00 | 3,480 |
| 7 Jul 2026 | Arthur Klausner | Former Independent Director | Intent to Sell (Form 144) | -5,000 | – | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,103,516 | 16.4% | 8.8 |
| 15 Oct 2026 | 1,128,617 | 16.8% | 7.1 |
| 30 Sep 2026 | 1,086,279 | 16.2% | 6.0 |
| 15 Sep 2026 | 844,226 | 12.6% | 7.2 |
| 31 Aug 2026 | 852,425 | 12.7% | 4.5 |
| 14 Aug 2026 | 887,188 | 13.2% | 3.5 |
No comments yet — be the first to weigh in on MNPR.
Sign in to join the discussion.